Difficulty: Medium
Average Score: 95%
Practice
Tick the antimycobacterial drug, belonging to antibiotics:
Correct answer
D
Rationale
In the context of Lifespan Pharmacology, understanding antimycobacterial drugs is crucial for managing conditions like tuberculosis. In this question, the correct answer is D) Rifampin. Rifampin is an antimycobacterial drug commonly used in the treatment of tuberculosis. It works by inhibiting RNA synthesis in mycobacteria, making it an effective treatment option.
A) Isoniazid is also used to treat tuberculosis, but it is specifically a first-line drug that acts by inhibiting the synthesis of mycolic acids in mycobacteria, not RNA synthesis like Rifampin.
B) PAS (para-aminosalicylic acid) is another antimycobacterial drug, but it is not commonly used today due to its side effects and the availability of more effective drugs like Rifampin and Isoniazid.
C) Ethambutol is an antimycobacterial drug used in the treatment of tuberculosis as well, but it works by inhibiting the synthesis of arabinogalactan in mycobacteria, not RNA synthesis like Rifampin.
Understanding the mechanisms of action of these drugs is essential for healthcare professionals to make informed decisions in prescribing the most appropriate treatment for patients with mycobacterial infections. This knowledge also helps in preventing drug resistance and ensuring successful treatment outcomes in patients.
A) Isoniazid is also used to treat tuberculosis, but it is specifically a first-line drug that acts by inhibiting the synthesis of mycolic acids in mycobacteria, not RNA synthesis like Rifampin.
B) PAS (para-aminosalicylic acid) is another antimycobacterial drug, but it is not commonly used today due to its side effects and the availability of more effective drugs like Rifampin and Isoniazid.
C) Ethambutol is an antimycobacterial drug used in the treatment of tuberculosis as well, but it works by inhibiting the synthesis of arabinogalactan in mycobacteria, not RNA synthesis like Rifampin.
Understanding the mechanisms of action of these drugs is essential for healthcare professionals to make informed decisions in prescribing the most appropriate treatment for patients with mycobacterial infections. This knowledge also helps in preventing drug resistance and ensuring successful treatment outcomes in patients.